BioLife Solutions Inc (BLFS)
Profitability ratios
Return on sales
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 25.26% | 6.44% | 21.42% | -18.90% | -17.58% | 5.54% | 2.68% | 51.90% | 52.63% | 66.76% | 65.04% | 55.83% | 48.59% | -19.13% | -10.48% | 2.50% | 10.94% | 68.28% | 68.59% | 68.66% |
| Operating profit margin | -49.60% | -69.44% | -55.69% | -93.06% | -90.38% | -74.28% | -77.38% | -30.50% | -29.59% | -22.89% | -16.46% | -14.39% | -12.98% | -3.86% | -3.05% | -1.24% | -0.80% | 6.31% | 14.94% | 18.47% |
| Pretax margin | -46.40% | -66.30% | -52.04% | -92.60% | -89.94% | -73.72% | -73.12% | -26.00% | -24.43% | -17.37% | -17.56% | -46.82% | -2.66% | 15.12% | 48.10% | 113.94% | -11.69% | -14.93% | -53.80% | -71.83% |
| Net profit margin | -46.52% | -66.38% | -51.68% | -89.93% | -86.82% | -68.86% | -65.05% | -11.01% | -7.50% | 4.17% | 3.80% | -40.63% | 4.12% | 18.86% | 52.30% | 118.52% | -6.05% | 64.94% | -77.61% | -221.56% |
BioLife Solutions Inc's profitability ratios have shown significant fluctuations over the past few quarters. The gross profit margin has varied widely, ranging from negative figures to as high as 66.76%, indicating inconsistencies in the company's ability to generate profits from its core operations.
The operating profit margin has also been unstable, with negative values consistently recorded, indicating that the company is struggling to control its operating expenses relative to its revenue. This trend suggests operational inefficiencies that need to be addressed to improve profitability.
The pretax margin has also shown volatility, with negative margins prevailing in most periods. This indicates that non-operational factors, such as interest expenses or tax burdens, are impacting the company's overall profitability.
Similarly, the net profit margin has been erratic, with negative margins in many quarters. This suggests that after accounting for all expenses, including taxes, the company is not effectively translating its revenue into bottom-line profits.
Overall, BioLife Solutions Inc's profitability ratios reflect a concerning trend of inconsistency and inefficiency in generating profits. Management should focus on cost control and operational improvements to enhance profitability and ensure long-term sustainability.
Return on investment
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -17.16% | -26.01% | -20.75% | -33.86% | -32.33% | -23.51% | -24.25% | -7.74% | -6.34% | -3.95% | -2.34% | -3.16% | -2.66% | -0.81% | -0.98% | -0.44% | -0.24% | 1.89% | 6.92% | 8.51% |
| Return on assets (ROA) | -16.10% | -24.87% | -19.26% | -32.72% | -31.05% | -21.79% | -20.39% | -2.79% | -1.61% | 0.72% | 0.54% | -8.93% | 0.84% | 3.97% | 16.83% | 41.91% | -1.79% | 19.45% | -35.95% | -102.01% |
| Return on total capital | -19.90% | -30.30% | -23.93% | -39.60% | -37.51% | -26.72% | -27.46% | -8.74% | -7.26% | -4.46% | -2.64% | -11.40% | -0.30% | 3.34% | 16.67% | 56.53% | -7.37% | -10.21% | -611.34% | — |
| Return on equity (ROE) | -19.67% | -30.79% | -23.69% | -40.80% | -38.39% | -26.25% | -23.43% | -3.20% | -1.86% | 0.82% | 0.62% | -10.27% | 0.97% | 4.16% | 18.12% | 58.80% | -3.82% | 46.30% | -890.01% | — |
BioLife Solutions Inc has experienced negative trends in its profitability ratios over the past several quarters. The company's operating return on assets (Operating ROA), which indicates how efficiently the company is utilizing its assets to generate operating income, has been consistently negative, reflecting a decline in operational efficiency.
Similarly, the return on assets (ROA) and return on total capital ratios have also been negative, showing that the company is not effectively utilizing its total assets and capital to generate profits. These ratios indicate a downward trend in the company's ability to generate earnings from its resources.
The return on equity (ROE) ratio, which measures the return on shareholders' equity, has also been decreasing consistently, indicating a decline in the company's ability to generate profits for its equity investors.
Overall, the deteriorating profitability ratios suggest that BioLife Solutions Inc is facing challenges in generating profits from its operations and efficiently utilizing its resources. The company may need to reevaluate its business strategies and operational efficiency to improve its profitability in the future.